Complementary analyses of the AMBAR trial: Individual items of CDR and ADAS‐Cog12 in Alzheimer’s disease patients treated with plasma exchange with albumin replacement
Year: 2021
Type: article
Source: Alzheimer s & Dementia
DOI: 10.1002/alz.053717
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: Alzheimer's disease, plasma exchange
Open Access status: closed
OpenAlex ID: W4205379792
